UnknownNot applicableNCT03327285

C-CAR011 Treatment in Subjects With ALL After HSCT

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Peking University People's Hospital
Principal Investigator
Xiaojun Huang
Peking University People's Hospital
Intervention
C-CAR011(biological)
Enrollment
40 enrolled
Eligibility
15-65 years · All sexes
Timeline
20182021

Study locations (1)

Collaborators

Shanghai AbelZeta Ltd.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03327285 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials